HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 91 filers reported holding HARVARD BIOSCIENCE INC in Q1 2024. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,199,922 | $6,269,778 | 8.31% |
| 272 Capital LP | 1,535,820 | $4,377,087 | 2.19% |
| Meros Investment Management, LP | 835,213 | $2,380,357 | 1.13% |
| Harvey Partners, LLC | 2,557,500 | $7,288,875 | 0.88% |
| Acuitas Investments, LLC | 407,343 | $1,160,928 | 0.62% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,772,339 | $7,901,166 | 0.46% |
| BARD ASSOCIATES INC | 296,995 | $846,436 | 0.32% |
| Riverwater Partners LLC | 105,977 | $302,034 | 0.22% |
| Granahan Investment Management | 1,925,398 | $5,487,384 | 0.22% |
| HEARTLAND ADVISORS INC | 1,200,000 | $3,420,000 | 0.19% |